PL3048165T3 - Nowy szczep bifidobacterium animalis subsp. lactis cect 8145 oraz jego stosowanie w leczeniu nadwagi, otyłości i powiązanych chorób i/lub zapobieganiu im - Google Patents

Nowy szczep bifidobacterium animalis subsp. lactis cect 8145 oraz jego stosowanie w leczeniu nadwagi, otyłości i powiązanych chorób i/lub zapobieganiu im

Info

Publication number
PL3048165T3
PL3048165T3 PL14755102T PL14755102T PL3048165T3 PL 3048165 T3 PL3048165 T3 PL 3048165T3 PL 14755102 T PL14755102 T PL 14755102T PL 14755102 T PL14755102 T PL 14755102T PL 3048165 T3 PL3048165 T3 PL 3048165T3
Authority
PL
Poland
Prior art keywords
obesity
prevention
treatment
associated diseases
bifidobacterium animalis
Prior art date
Application number
PL14755102T
Other languages
English (en)
Inventor
Patricia Martorell Guerola
Mª Empar CHENOLL CUADROS
Daniel RAMÓN VIDAL
Pepa ORTIZ SERRANO
Silvia Llopis Pla
Núria GONZALEZ MARTÍNEZ
Salvador GENOVÉS MARTÍNEZ
Beatriz Casinos Ramo
Ángela SILVA ANGULO
Amaya ALEIXANDRE
Original Assignee
Biopolis, S.L.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biopolis, S.L. filed Critical Biopolis, S.L.
Publication of PL3048165T3 publication Critical patent/PL3048165T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; PREPARATION THEREOF
    • A23C11/00—Milk substitutes, e.g. coffee whitener compositions
    • A23C11/02—Milk substitutes, e.g. coffee whitener compositions containing at least one non-milk component as source of fats or proteins
    • A23C11/10—Milk substitutes, e.g. coffee whitener compositions containing at least one non-milk component as source of fats or proteins containing or not lactose but no other milk components as source of fats, carbohydrates or proteins
    • A23C11/103—Milk substitutes, e.g. coffee whitener compositions containing at least one non-milk component as source of fats or proteins containing or not lactose but no other milk components as source of fats, carbohydrates or proteins containing only proteins from pulses, oilseeds or nuts, e.g. nut milk
    • A23C11/106—Addition of, or treatment with, microorganisms
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; PREPARATION THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/123—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
    • A23C9/1234—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt characterised by using a Lactobacillus sp. other than Lactobacillus Bulgaricus, including Bificlobacterium sp.
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L11/00—Pulses, i.e. fruits of leguminous plants, for production of food; Products from legumes; Preparation or treatment thereof
    • A23L11/60—Drinks from legumes, e.g. lupine drinks
    • A23L11/65—Soy drinks
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
    • A23L2/02—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof containing fruit or vegetable juices
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
    • A23L2/38—Other non-alcoholic beverages
    • A23L2/382—Other non-alcoholic beverages fermented
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
    • A23L2/52—Adding ingredients
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/51—Bifidobacterium
    • A23V2400/515—Animalis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K2035/11—Medicinal preparations comprising living procariotic cells
    • A61K2035/115—Probiotics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Agronomy & Crop Science (AREA)
  • Botany (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Child & Adolescent Psychology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
PL14755102T 2013-07-18 2014-07-17 Nowy szczep bifidobacterium animalis subsp. lactis cect 8145 oraz jego stosowanie w leczeniu nadwagi, otyłości i powiązanych chorób i/lub zapobieganiu im PL3048165T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ES201331088A ES2526986B1 (es) 2013-07-18 2013-07-18 Nueva cepa de Bifidobacterium animalis subsp. lactis CECT 8145 y su uso para el tratamiento y/o prevención de sobrepeso y obesidad y enfermedades asociadas
PCT/ES2014/070579 WO2015007941A1 (es) 2013-07-18 2014-07-17 Nueva cepa de bifidobacterium animalis subsp. lactis cect 8145 y su uso para el tratamiento y/o prevención de sobrepeso y obesidad y enfermedades asociadas
EP14755102.2A EP3048165B1 (en) 2013-07-18 2014-07-17 Novel strain of bifidobacterium animalis subsp. lactis cect 8145 and use thereof for the treatment and/or prevention of excess weight and obesity and associated diseases

Publications (1)

Publication Number Publication Date
PL3048165T3 true PL3048165T3 (pl) 2018-06-29

Family

ID=51392276

Family Applications (1)

Application Number Title Priority Date Filing Date
PL14755102T PL3048165T3 (pl) 2013-07-18 2014-07-17 Nowy szczep bifidobacterium animalis subsp. lactis cect 8145 oraz jego stosowanie w leczeniu nadwagi, otyłości i powiązanych chorób i/lub zapobieganiu im

Country Status (20)

Country Link
US (1) US10946051B2 (pl)
EP (1) EP3048165B1 (pl)
CN (1) CN105849248B (pl)
AU (1) AU2014291922B2 (pl)
CA (1) CA2918430C (pl)
CY (1) CY1119770T1 (pl)
DK (1) DK3048165T3 (pl)
ES (2) ES2526986B1 (pl)
HK (1) HK1226100B (pl)
HR (1) HRP20180053T1 (pl)
HU (1) HUE035501T2 (pl)
LT (1) LT3048165T (pl)
MX (1) MX367132B (pl)
NO (1) NO3048165T3 (pl)
PL (1) PL3048165T3 (pl)
PT (1) PT3048165T (pl)
RS (1) RS56826B1 (pl)
SI (1) SI3048165T1 (pl)
SM (1) SMT201800072T1 (pl)
WO (1) WO2015007941A1 (pl)

Families Citing this family (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105002130A (zh) * 2015-07-30 2015-10-28 江南大学 一种产胆盐水解酶的基因工程菌及其构建方法与应用
EP3222282A1 (en) * 2016-03-21 2017-09-27 Bionou Research, S.L. Use of probiotics in the treatment and/or prevention of psoriasis
CN105918460A (zh) * 2016-04-11 2016-09-07 西南民族大学 一种益生菌谷物酸奶及其制备方法
AU2017249661B2 (en) * 2016-04-14 2020-03-19 International N&H Denmark Aps Bifidobacteria for reducing food, energy and/or fat intake
EP3272396A1 (en) * 2016-07-18 2018-01-24 Bionou Research, S.L. Use of probiotics in the treatment and/or prevention of atopic dermatitis
IT201600091033A1 (it) * 2016-09-08 2018-03-08 Bioimmunizer Sagl Ceppi di batteri probiotici appartenenti al genere Bifidobacterium e loro estratti di cellule probiotiche (ECP) aventi proprietà immunostimolanti.
CN109223833A (zh) * 2017-07-10 2019-01-18 上海立龙生物科技有限公司 一种预防和改善肥胖的益生菌组合物
US11833178B2 (en) 2017-08-25 2023-12-05 University College Cork—National University of Ireland, Cork Bifidobacterium longum for treating obesity and weight management
CN107699517A (zh) * 2017-10-17 2018-02-16 无限极(中国)有限公司 一种青春双歧杆菌及其用途
PL3489350T3 (pl) * 2017-11-27 2022-01-24 Ewelina Sosnowska-Turek Szczep Bifidobacterium animalis AMT30 i kompozycja zawierająca szczep Bifidobacterium animalis AMT30
CN111954536A (zh) * 2018-03-23 2020-11-17 森永乳业株式会社 用于预防学龄期及之后的高血糖引起的疾病的婴幼儿用组合物
CN112236154B (zh) * 2018-05-31 2024-10-18 深圳华大生命科学研究院 一种组合物及其应用
WO2020063553A1 (zh) 2018-09-30 2020-04-02 内蒙古伊利实业集团股份有限公司 一种乳双歧杆菌bl-99及其应用
CN109182207B (zh) * 2018-10-10 2020-10-27 北京首佳利华科技有限公司 一株具有调节血糖和胆固醇水平等益生功能的嗜酸乳杆菌La-SJLH001及其应用
CN109749955B (zh) * 2018-12-29 2020-08-21 浙江工业大学 短乳杆菌zj401及其应用
CN109666615B (zh) * 2019-02-20 2021-03-19 无限极(中国)有限公司 一种益生菌组合物及其应用
US11045507B2 (en) 2019-02-21 2021-06-29 Ewelina Sosnowska-Turek Bifidobacterium animalis AMT30 strain and the composition containing the strain of Bifidobacterium animalis AMT30
CN115279380A (zh) * 2019-12-27 2022-11-01 佰欧波利斯有限公司 来自双歧杆菌的脂磷壁酸的用途
EP3851115A1 (en) * 2020-01-15 2021-07-21 Biopolis, S.L. Probiotic composition for its use as an antioxidant
KR102136522B1 (ko) * 2020-03-04 2020-07-22 주식회사 락토메이슨 안전성 및 장부착능이 우수한 모유유래 락토바실러스 루테리 lm1071 균주, 및 상기 균주 또는 이의 배양물을 포함하는 조성물
CN111849836B (zh) * 2020-08-08 2023-09-22 洪德轩 一种具有抗氧化的鼠李糖乳杆菌及其应用
CN116076569B (zh) * 2020-08-31 2025-05-13 内蒙古蒙牛乳业(集团)股份有限公司 MN-Gup制备缓解肥胖或体重增加的乳制品中的用途
EP4001399A1 (en) * 2020-11-13 2022-05-25 "NEOPHARM BULGARIA" Ltd. Strain bifidobacterium animalis ssp. lactis dsm 33647 for modulating metabolism indicators
CN112618577B (zh) * 2020-12-15 2023-07-25 深圳君拓生物科技有限公司 动物双歧杆菌在提高肿瘤免疫治疗应答中的作用
US20240050494A1 (en) * 2020-12-18 2024-02-15 The General Hospital Corporation Probiotics compositions and method of using the same to enhance growth and social function in children
CN112980719B (zh) * 2020-12-30 2022-11-29 上海理工大学 一株耐氧动物双歧杆菌
CN113005060B (zh) * 2021-03-15 2022-11-01 江南大学 青春双歧杆菌ccfm1173在制备功能性菌剂、食品和或药物中的应用
US20240350565A1 (en) * 2021-08-19 2024-10-24 Societe Des Produits Nestle S.A. Postbiotic
WO2023021140A1 (en) * 2021-08-19 2023-02-23 Société des Produits Nestlé S.A. Postbiotic
CN114200120A (zh) * 2021-12-02 2022-03-18 兰州大学 一种治疗肥胖症的药物筛选试剂盒及其使用方法
CN114028444A (zh) * 2021-12-03 2022-02-11 南京北极光生物科技有限公司 一种益生菌组合物及其在缓解抑郁症与减少脂堆积上的应用
WO2023118868A1 (en) * 2021-12-21 2023-06-29 Quadram Institute Bioscience Bifidobacterium and compositions thereof for breast cancer treatment
CN114317354B (zh) * 2021-12-30 2024-05-07 美益添生物医药(武汉)有限公司 一种动物双歧杆菌及其培养方法和其在促进骨细胞生长和成熟中的应用
CN114480229B (zh) * 2022-04-15 2022-08-09 微康益生菌(苏州)股份有限公司 一种动物双歧杆菌乳亚种菌株wkb148及其产品与应用
JP2025514761A (ja) 2022-04-21 2025-05-09 アボット・ラボラトリーズ 糖尿病の発症を遅らせる又は糖尿病のリスクを軽減するための方法及び組成物
CN114574407B (zh) * 2022-05-06 2022-11-01 微康益生菌(苏州)股份有限公司 动物双歧杆菌乳亚种wkb99及其在制备改善代谢综合征制品方面的应用和产品
CN114848683B (zh) * 2022-05-09 2023-10-24 上海交通大学医学院附属瑞金医院 一种长双歧杆菌在制备预防或治疗多囊卵巢所致不孕症药物中的应用
CN115181698B (zh) * 2022-06-28 2023-09-08 广东粤港澳大湾区国家纳米科技创新研究院 一种益生菌组合物及应用
CN116286551B (zh) * 2023-04-25 2023-08-11 天赋能(天津)功能食品研究发展有限公司 长双歧杆菌婴儿亚种在调节体内脂肪代谢、塑形减脂改善肥胖方面的应用
CN116622585A (zh) * 2023-06-20 2023-08-22 广东南芯医疗科技有限公司 动物双歧杆菌乳亚种bl03在制备抗氧化和抗衰老产品中的应用
WO2025008468A1 (en) * 2023-07-04 2025-01-09 Biopolis, S.L. Bifidobacterium animalis subsp lactis strain cect 8145 and lta thereof health uses
CN116590205B (zh) * 2023-07-14 2023-10-03 中国农业大学 一种动物双歧杆菌亚种组合菌剂在减肥制剂制备中的应用
CN117448198B (zh) * 2023-09-13 2025-03-11 杭州微致生物科技有限公司 一种动物双歧杆菌乳亚种vb301及其应用
CN117025489B (zh) * 2023-10-09 2024-03-19 杭州微致生物科技有限公司 一种动物双歧杆菌乳亚种vb315及其应用
KR20260117773A (ko) * 2023-11-30 2026-07-29 코리 컴퍼니 리미티드 비피도박테리움 애니말리스 서브스피시스 락티스 균주, 프로바이오틱스 제제 및 이의 제조 방법과 용도
CN117535200A (zh) * 2023-11-30 2024-02-09 科郦有限公司 一种动物双歧杆菌乳亚种菌株及其用途
CN118240724B (zh) * 2024-05-30 2024-08-16 内蒙古农业大学 一株动物双歧杆菌乳亚种ProSci-246及由其制备的产品和应用
CN118902102A (zh) * 2024-10-11 2024-11-08 浙江衡美健康科技股份有限公司 一种促进减脂的六重组合物及其制备方法和应用
CN119174784B (zh) * 2024-11-14 2025-03-04 华大精准营养(深圳)科技有限公司 动物双歧杆菌乳亚种或组合物在制备用于预防和/或治疗代谢性疾病的产品中的应用
WO2026132482A1 (en) * 2024-12-19 2026-06-25 Biopolis, S.L. Tea extract and bifidobacterium animalis subsp. lactis strain combination
CN119709540B (zh) * 2025-01-14 2026-03-27 天津大学浙江研究院(绍兴) 假小链双歧杆菌及其应用
WO2026162785A1 (en) * 2025-01-31 2026-08-06 Itf Research Pharma, S.L.U. Probiotic composition and use thereof for improving woman fertility
CN119909105A (zh) * 2025-04-02 2025-05-02 合生元(广州)健康产品有限公司 一种用于降脂降糖的营养组合物及其应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007029773A1 (ja) * 2005-09-08 2007-03-15 Kabushiki Kaisha Yakult Honsha コレステロール吸収抑制剤
SE529185C2 (sv) * 2005-10-07 2007-05-22 Arla Foods Amba Användning av probiotiska bakterier för tillverkning av livsmedel eller läkemedel för förhindrande av övervikt
US20110027348A1 (en) 2007-08-27 2011-02-03 Janos Feher Composition and method inhibiting inflammation
EP3181134B1 (en) * 2009-06-19 2019-10-30 DuPont Nutrition Biosciences ApS Bifidobacteria for treating diabetes and related conditions
ES2543738T3 (es) * 2010-01-08 2015-08-21 Compagnie Gervais Danone Método para seleccionar bacterias con acción antioxidante
JP2011172506A (ja) * 2010-02-24 2011-09-08 Glico Dairy Products Co Ltd プロバイオティクス用のビフィドバクテリウム・アニマリス・サブスピーシーズ・ラクティス菌株及びこれを用いたプロバイオティクス乳酸菌発酵食品又はその他のプロバイオティクス経口食品。
PL2685994T3 (pl) * 2011-03-17 2016-05-31 Probiotical Spa Bakterie probiotyczne wykazujące aktywność przeciwutleniającą i ich zastosowanie

Also Published As

Publication number Publication date
DK3048165T3 (en) 2018-01-22
CA2918430A1 (en) 2015-01-22
PT3048165T (pt) 2018-02-09
LT3048165T (lt) 2018-03-12
EP3048165B1 (en) 2017-10-11
AU2014291922A1 (en) 2016-02-25
HUE035501T2 (en) 2018-05-02
WO2015007941A1 (es) 2015-01-22
US10946051B2 (en) 2021-03-16
RS56826B1 (sr) 2018-04-30
MX2016000743A (es) 2016-07-14
SI3048165T1 (en) 2018-04-30
CY1119770T1 (el) 2018-06-27
MX367132B (es) 2019-08-05
US20160143963A1 (en) 2016-05-26
ES2526986A1 (es) 2015-01-19
SMT201800072T1 (it) 2018-03-08
HRP20180053T1 (hr) 2018-03-23
AU2014291922B2 (en) 2019-11-14
CN105849248A (zh) 2016-08-10
ES2655857T3 (es) 2018-02-21
EP3048165A1 (en) 2016-07-27
CN105849248B (zh) 2020-05-05
HK1226100B (en) 2017-09-22
CA2918430C (en) 2023-06-06
ES2526986B1 (es) 2015-11-02
NO3048165T3 (pl) 2018-03-10

Similar Documents

Publication Publication Date Title
LT3048165T (lt) Naujasis bifidobacterium animalis subsp. lactis cect 8145 štamas ir jo panaudojimas viršsvorio ir nutukimo ir susijusių ligų gydymui ir (arba) prevencijai
IL265774B (en) Diagnosis, prevention and treatment of joint diseases
PL3554522T3 (pl) Probiotyki do stosowania w leczeniu uchyłkowatości i chorobyuchyłkowej
PL3016667T3 (pl) Probiotyczne szczepy bakteryjne do zapobiegania i leczenia chorób w jamie ustnej
IN2015DN02032A (pl)
PL3212208T3 (pl) Zastosowanie bakterii l. reuteri do zapobiegania lub leczenia dysbiozy mikrobioty we wczesnych fazach życia
PL2990045T3 (pl) Bifidobacterium animalis podgat. lactis do stosowania w zmniejszaniu bólu brzucha u kobiet po menopauzie
DK2802333T3 (da) Lactobacillus rhamnosus og Bifidobacterium animalis subsp. lactis til anvendelse til forebyggelse eller behandling af øvre luftvejsinfektioner
WO2015121458A3 (fr) Utilisations de compositions comprenant du bifidobacterium animalis ssp. lactis lmg p-28149
GB201600975D0 (en) Novel strain of probiotic bacteria and compositions and uses thereof
SG11202013207XA (en) Graphene product and therapeutic uses thereof
MX2015005897A (es) Cepa de lactobacillus rhamnosus para reducir la acumulacion de grasa corporal.
SG11201502781PA (en) Formulations for the treatment and prevention of obesity
IL248935A0 (en) Diagnostic testing and treatment/prevention of Alzheimer's disease
PL3137097T3 (pl) Leczenie i profilaktyka choroby Alzheimera (AD)
ZA201607245B (en) Maternal vitamin b2 administration for the prevention of increased adiposity, overweight or obesity in the offspring
PL3137094T3 (pl) Leczenie i profilaktyka choroby alzheimera (ad)
PL3489350T3 (pl) Szczep Bifidobacterium animalis AMT30 i kompozycja zawierająca szczep Bifidobacterium animalis AMT30
PT3408373T (pt) Estirpe bacteriana como agente para evitar e/ou tratar distúrbios respiratórios
PL3137093T3 (pl) Leczenie i profilaktyka choroby Alzheimera (AD)
PT3664800T (pt) Formulações terapêuticas que compreendem inibidor da cox-2 e utilizações das mesmas
LT2922541T (lt) Piridilo hidrazonai, skirti tuberkuliozės ir susijusių ligų gydymui
GB201608841D0 (en) Use of neurotoxin in the treatment of overweight, including obesity
CN302205261S (zh) 塑身裤
TH1501007339A (th) ที่นอนปรับสมดุลที่กระจายแรงโน้มถ่วงของร่างกายมนุษย์